Renato de Castro Capuzzo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Renato de Castro Capuzzo has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- André Lopes Carvalho
Early Detection, Prevention & Infections Branch International Agency for Research on Cancer Lyon France
5 shared publications - José Guilherme Vartanian
Sociedade Brasileira de Cirurgia de Cabeça e Pescoço São Paulo, Brasil; Sociedade Brasileira de Cirurgia Oncológica Rio de Janeiro, Brasil
5 shared publications - Fernando Luiz Dias
Instituto Nacional de Câncer (INCA), Departamento de Cirurgia de Cabeça e Pescoço. Rio de Janeiro (RJ), Brasil
4 shared publications - Fátima Cristina Mendes de Matos
Sociedade Brasileira de Cirurgia de Cabeça e Pescoço São Paulo, Brasil
4 shared publications - Leandro Luongo Matos
Head and Neck Surgery, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Universidade de São Paulo (Icesp HCFMUSP). Professor, Surgery, Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, Brazil
4 shared publications - Luiz Paulo Kowalski
Head and Neck Surgery Department University of São Paulo Medical School (FMUSP) São Paulo Brazil
4 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 52
Revisão técnica da SBCO e SBCCP sobre a codificação hierarquizada na cirurgia de tireoide
RESUMO A Sociedade Brasileira de Cirurgia Oncológica e a Sociedade Brasileira de Cirurgia de Cabeça e Pescoço elaboraram um consenso técnico sobre a codificação hierarquizada na cirurgia da tireoide, considerando o papel da Classificação Brasileira Hierarquizada de Procedimentos Médicos no enquadramento das indicações para cada cirurgia. O documento foi elaborado por um colegiado de 40 especialistas, reconhecidas lideranças de representatividade acadêmica e assistencial, provenientes de diferentes regiões do país, que avaliaram a pertinência dos códigos aplicáveis às principais cirurgias da tireoide. As deliberações foram realizadas por meio de votação eletrônica entre 37 participantes, sendo o consenso estabelecido quando se atingiu concordância ≥ 80%. Foram avaliados cenários de tireoidectomia total para doenças benignas, malignas e para ressecção de bócio mergulhante, incluindo códigos de exploração de nervos laríngeos, monitorização neurofisiológica, ligadura de ramos da carótida, biópsia e reimplante de paratireoide, linfadenectomia e esvaziamentos cervicais. Houve consenso favorável à pertinência dos seguintes códigos: exploração de nervos (83,3%), monitorização neurofisiológica (97,3%), biópsia e reimplante de paratireoide (89,2%), linfadenectomia cervical (89,2%) e esvaziamentos uni ou bilaterais (97,3% e 94,6%), ratificando a utilização destes códigos. Não houve consenso para inclusão do código de ligadura da carótida e/ou ramos nem para agregar um código de tireoidectomia parcial em casos de bócio mergulhante apenas unilateral, afastando a validação destes. O consenso fornece normatização clara e objetiva para a codificação hierarquizada nas cirurgias da tireoide, fundamentada em critérios técnico-científicos e éticos. Destina-se a orientar médicos assistentes e auditores, promovendo uniformidade, transparência e redução de conflitos na prática clínica e administrativa.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 52
Open AccessRevisão técnica da SBCO e SBCCP sobre a codificação hierarquizada na cirurgia de tireoide
RESUMO A Sociedade Brasileira de Cirurgia Oncológica e a Sociedade Brasileira de Cirurgia de Cabeça e Pescoço elaboraram um consenso técnico sobre a codificação hierarquizada na cirurgia da tireoide, considerando o papel da Classificação Brasileira Hierarquizada de Procedimentos Médicos no enquadramento das indicações para cada cirurgia. O documento foi elaborado por um colegiado de 40 especialistas, reconhecidas lideranças de representatividade acadêmica e assistencial, provenientes de diferentes regiões do país, que avaliaram a pertinência dos códigos aplicáveis às principais cirurgias da tireoide. As deliberações foram realizadas por meio de votação eletrônica entre 37 participantes, sendo o consenso estabelecido quando se atingiu concordância ≥ 80%. Foram avaliados cenários de tireoidectomia total para doenças benignas, malignas e para ressecção de bócio mergulhante, incluindo códigos de exploração de nervos laríngeos, monitorização neurofisiológica, ligadura de ramos da carótida, biópsia e reimplante de paratireoide, linfadenectomia e esvaziamentos cervicais. Houve consenso favorável à pertinência dos seguintes códigos: exploração de nervos (83,3%), monitorização neurofisiológica (97,3%), biópsia e reimplante de paratireoide (89,2%), linfadenectomia cervical (89,2%) e esvaziamentos uni ou bilaterais (97,3% e 94,6%), ratificando a utilização destes códigos. Não houve consenso para inclusão do código de ligadura da carótida e/ou ramos nem para agregar um código de tireoidectomia parcial em casos de bócio mergulhante apenas unilateral, afastando a validação destes. O consenso fornece normatização clara e objetiva para a codificação hierarquizada nas cirurgias da tireoide, fundamentada em critérios técnico-científicos e éticos. Destina-se a orientar médicos assistentes e auditores, promovendo uniformidade, transparência e redução de conflitos na prática clínica e administrativa.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 52, e20250024
Technical review by the Brazilian Society of Surgical Oncology and the Brazilian Society of Head and Neck Surgery on hierarchical coding in thyroid surgery
The Brazilian Society of Surgical Oncology and the Brazilian Society of Head and Neck Surgery developed a technical consensus on hierarchical coding in thyroid surgery, considering the role of the Brazilian Hierarchical Classification of Medical Procedures in determining appropriate codes. A panel of 40 specialists - recognized academic and clinical leaders from across Brazil - assessed the applicability of procedure codes for common thyroid surgeries and prepared the current consensus. Deliberations were conducted via electronic voting among 37 participants, and consensus was defined as agreement by at least 80%. Scenarios included total thyroidectomy for benign and malignant disease and resection of substernal goiter. The analysis covered codes for laryngeal nerve exploration, neurophysiological monitoring, carotid artery branch ligation, biopsy, parathyroid reimplantation, lymphadenectomy, and neck dissection. Consensus supported the use of the following codes: nerve exploration (83.3%), neurophysiological monitoring (97.3%), biopsy and parathyroid reimplantation (89.2%), cervical lymphadenectomy (89.2%), and unilateral or bilateral neck dissections (97.3% and 94.6%, respectively). No consensus was reached on including carotid artery branch ligation or adding a partial thyroidectomy code for unilateral substernal goiter; therefore, these codes were not validated. The current consensus provides clear, objective guidance on hierarchical coding for thyroid surgery based on technical, scientific, and ethical criteria. It is intended to support attending physicians and auditors by promoting consistency, transparency, and reduced conflict in clinical and administrative settings.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 52, e20250024
Open AccessTechnical review by the Brazilian Society of Surgical Oncology and the Brazilian Society of Head and Neck Surgery on hierarchical coding in thyroid surgery
The Brazilian Society of Surgical Oncology and the Brazilian Society of Head and Neck Surgery developed a technical consensus on hierarchical coding in thyroid surgery, considering the role of the Brazilian Hierarchical Classification of Medical Procedures in determining appropriate codes. A panel of 40 specialists - recognized academic and clinical leaders from across Brazil - assessed the applicability of procedure codes for common thyroid surgeries and prepared the current consensus. Deliberations were conducted via electronic voting among 37 participants, and consensus was defined as agreement by at least 80%. Scenarios included total thyroidectomy for benign and malignant disease and resection of substernal goiter. The analysis covered codes for laryngeal nerve exploration, neurophysiological monitoring, carotid artery branch ligation, biopsy, parathyroid reimplantation, lymphadenectomy, and neck dissection. Consensus supported the use of the following codes: nerve exploration (83.3%), neurophysiological monitoring (97.3%), biopsy and parathyroid reimplantation (89.2%), cervical lymphadenectomy (89.2%), and unilateral or bilateral neck dissections (97.3% and 94.6%, respectively). No consensus was reached on including carotid artery branch ligation or adding a partial thyroidectomy code for unilateral substernal goiter; therefore, these codes were not validated. The current consensus provides clear, objective guidance on hierarchical coding for thyroid surgery based on technical, scientific, and ethical criteria. It is intended to support attending physicians and auditors by promoting consistency, transparency, and reduced conflict in clinical and administrative settings.
- Open Access
- 10 June 2024
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 68, e240064
Thyroid surgery volume – A statement issued by the Brazilian Head and Neck Surgery Society (SBCCP)
DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement [...] DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement
- 10 June 2024
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 68, e240064
Open AccessThyroid surgery volume – A statement issued by the Brazilian Head and Neck Surgery Society (SBCCP)
DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement [...] DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement
- 1 April 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2300343
Latin American Consensus on the Treatment of Head and Neck Cancer
Head and neck squamous cell carcinoma (HNSCC) is well known as a serious health problem worldwide, especially in low-income countries or those with limited resources, such as most countries in Latin America. International guidelines cannot always be applied to a population from a large region with specific conditions. This study established a Latin American guideline for care of patients with head and neck cancer and presented evidence of HNSCC management considering availability and oncologic benefit. A panel composed of 41 head and neck cancer experts systematically worked according to a modified Delphi process on (1) document compilation of evidence-based answers to different questions contextualized by resource availability and oncologic benefit regarding Latin America (region of limited resources and/or without access to all necessary health care system infrastructure), (2) revision of the answers and the classification of levels of evidence and degrees of recommendations of all recommendations, (3) validation of the consensus through two rounds of online surveys, and (4) manuscript composition. The consensus consists of 12 sections: Head and neck cancer staging, Histopathologic evaluation of head and neck cancer, Head and neck surgery—oral cavity, Clinical oncology—oral cavity, Head and neck surgery—oropharynx, Clinical oncology—oropharynx, Head and neck surgery—larynx, Head and neck surgery—larynx/hypopharynx, Clinical oncology—larynx/hypopharynx, Clinical oncology—recurrent and metastatic head and neck cancer, Head and neck surgery—reconstruction and rehabilitation, and Radiation therapy. The present consensus established 48 recommendations on HNSCC patient care considering the availability of resources and focusing on oncologic benefit. These recommendations could also be used to formulate strategies in other regions like Latin America countries.
- 1 April 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2300343
Latin American Consensus on the Treatment of Head and Neck Cancer
Head and neck squamous cell carcinoma (HNSCC) is well known as a serious health problem worldwide, especially in low-income countries or those with limited resources, such as most countries in Latin America. International guidelines cannot always be applied to a population from a large region with specific conditions. This study established a Latin American guideline for care of patients with head and neck cancer and presented evidence of HNSCC management considering availability and oncologic benefit. A panel composed of 41 head and neck cancer experts systematically worked according to a modified Delphi process on (1) document compilation of evidence-based answers to different questions contextualized by resource availability and oncologic benefit regarding Latin America (region of limited resources and/or without access to all necessary health care system infrastructure), (2) revision of the answers and the classification of levels of evidence and degrees of recommendations of all recommendations, (3) validation of the consensus through two rounds of online surveys, and (4) manuscript composition. The consensus consists of 12 sections: Head and neck cancer staging, Histopathologic evaluation of head and neck cancer, Head and neck surgery—oral cavity, Clinical oncology—oral cavity, Head and neck surgery—oropharynx, Clinical oncology—oropharynx, Head and neck surgery—larynx, Head and neck surgery—larynx/hypopharynx, Clinical oncology—larynx/hypopharynx, Clinical oncology—recurrent and metastatic head and neck cancer, Head and neck surgery—reconstruction and rehabilitation, and Radiation therapy. The present consensus established 48 recommendations on HNSCC patient care considering the availability of resources and focusing on oncologic benefit. These recommendations could also be used to formulate strategies in other regions like Latin America countries.
- 30 September 2023
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 281 (1) , 351-357
Analysis of durability and replacement of vocal prostheses in total laryngectomy patients at a head and neck surgery referral center
Purpose The use of tracheoesophageal prostheses has become the gold standard in vocal rehabilitation of patients undergoing total laryngectomy. However, this method also has limitations, such as the need for frequent replacement of prostheses due to leakage or other complications. We have designed a study to access the clinical profile of patients using tracheoesophageal prostheses as vocal rehabilitation after total laryngectomy and to determine the average rate of changes, as well as the main causes of prostheses replacement. Methods A retrospective cohort study was performed based on patients who underwent rehabilitation with voice prostheses after total laryngectomy between 2008 and 2017. Results The sample consisted of 93 patients and 432 vocal prostheses replacement events. The median change of prostheses per patient was 210.25 days, (range 57.33 to 651.50). The most frequent cause of prostheses replacement was leakage through the prostheses, 218 (50.46%). Lower level of education was associated to higher prostheses replacement rate. Conclusion The results of this study show that the median of prostheses durability is higher than that presented in the literature, the main cause of replacement was protheses leakage and that low educational level is associated to higher replacement rate.
- 30 September 2023
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 281 (1) , 351-357
Analysis of durability and replacement of vocal prostheses in total laryngectomy patients at a head and neck surgery referral center
Purpose The use of tracheoesophageal prostheses has become the gold standard in vocal rehabilitation of patients undergoing total laryngectomy. However, this method also has limitations, such as the need for frequent replacement of prostheses due to leakage or other complications. We have designed a study to access the clinical profile of patients using tracheoesophageal prostheses as vocal rehabilitation after total laryngectomy and to determine the average rate of changes, as well as the main causes of prostheses replacement. Methods A retrospective cohort study was performed based on patients who underwent rehabilitation with voice prostheses after total laryngectomy between 2008 and 2017. Results The sample consisted of 93 patients and 432 vocal prostheses replacement events. The median change of prostheses per patient was 210.25 days, (range 57.33 to 651.50). The most frequent cause of prostheses replacement was leakage through the prostheses, 218 (50.46%). Lower level of education was associated to higher prostheses replacement rate. Conclusion The results of this study show that the median of prostheses durability is higher than that presented in the literature, the main cause of replacement was protheses leakage and that low educational level is associated to higher replacement rate.
- 31 July 2023
- Published by Wiley in Head & Neck
- Vol. 45 (10) , 2489-2497
miR‐99a‐5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients
Background: Metastatic lymph node involvement influences therapy decisions and serves as a prognostic indicator in oral squamous cell carcinoma (OSCC). However, many early‐stage patients with clinically negative lymph nodes exhibit no metastasis upon surgical staging. This study aimed to identify differentially expressed miRNAs capable of distinguishing pathologically positive (pN+) from negative (pN0) nodes in OSCC patients without clinical evidence of lymph node metastases (cN0).Methods: Expression levels of 798 miRNAs were assessed in tumor samples from 10 pN+ and 10 pN0 patients using the Nanostring nCounter platform. Validation was performed in an independent cohort of 15 pN+ and 24 pN0 patients through RT‐qPCR.Results: Eight miRNAs exhibited differential expression between pN0 and pN+ patients. Notably, hsa‐miR‐99a‐5p demonstrated high sensitivity and specificity in predicting patients at higher risk of positive lymph nodes.Conclusions: These findings highlight hsa‐miR‐99a‐5p as a potential biomarker for detecting lymph node metastasis in primary OSCC tumors.
- 31 July 2023
- Published by Wiley in Head & Neck
- Vol. 45 (10) , 2489-2497
miR‐99a‐5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients
Background: Metastatic lymph node involvement influences therapy decisions and serves as a prognostic indicator in oral squamous cell carcinoma (OSCC). However, many early‐stage patients with clinically negative lymph nodes exhibit no metastasis upon surgical staging. This study aimed to identify differentially expressed miRNAs capable of distinguishing pathologically positive (pN+) from negative (pN0) nodes in OSCC patients without clinical evidence of lymph node metastases (cN0).Methods: Expression levels of 798 miRNAs were assessed in tumor samples from 10 pN+ and 10 pN0 patients using the Nanostring nCounter platform. Validation was performed in an independent cohort of 15 pN+ and 24 pN0 patients through RT‐qPCR.Results: Eight miRNAs exhibited differential expression between pN0 and pN+ patients. Notably, hsa‐miR‐99a‐5p demonstrated high sensitivity and specificity in predicting patients at higher risk of positive lymph nodes.Conclusions: These findings highlight hsa‐miR‐99a‐5p as a potential biomarker for detecting lymph node metastasis in primary OSCC tumors.
- 15 April 2022
- Published by Wiley in Head & Neck
- Vol. 44 (7) , 1604-1615
Sentinel lymph node biopsy for early squamous cell carcinoma of the lip and oral cavity: Real‐world experience in Brazil
Background: This study aimed to evaluate the accuracy and oncological results of sentinel lymph node biopsy in patients with early lip and oral cavity squamous cell carcinoma (SCC) in a real‐world scenario.Methods: Retrospective study including seven Brazilian centers.Results: Four‐hundred and seven cN0 patients were accrued for 20 years. The rate of occult metastasis was 23.1% and 22 patients (5.4%) had regional failure. We found, for 5 years of follow‐up, 85.3% of regional recurrence‐free survival; 77.1% of disease‐free survival; 73.7% of overall survival; and 86.7% of disease‐specific survival. The rate of false‐negative cases was 5.4%.Conclusion: In a real‐world scenario, sentinel lymph node biopsy for patients with SCC of the lip and oral cavity proved feasible in different settings and to be oncologically safe, with similar rates of occult lymph node metastasis and false‐negative cases, when compared to elective neck dissection, and with similar long‐term survival to that reported historically.
- 15 April 2022
- Published by Wiley in Head & Neck
- Vol. 44 (7) , 1604-1615
Sentinel lymph node biopsy for early squamous cell carcinoma of the lip and oral cavity: Real‐world experience in Brazil
Background: This study aimed to evaluate the accuracy and oncological results of sentinel lymph node biopsy in patients with early lip and oral cavity squamous cell carcinoma (SCC) in a real‐world scenario.Methods: Retrospective study including seven Brazilian centers.Results: Four‐hundred and seven cN0 patients were accrued for 20 years. The rate of occult metastasis was 23.1% and 22 patients (5.4%) had regional failure. We found, for 5 years of follow‐up, 85.3% of regional recurrence‐free survival; 77.1% of disease‐free survival; 73.7% of overall survival; and 86.7% of disease‐specific survival. The rate of false‐negative cases was 5.4%.Conclusion: In a real‐world scenario, sentinel lymph node biopsy for patients with SCC of the lip and oral cavity proved feasible in different settings and to be oncologically safe, with similar rates of occult lymph node metastasis and false‐negative cases, when compared to elective neck dissection, and with similar long‐term survival to that reported historically.
- Open Access
- 13 August 2021
- Published by Georg Thieme Verlag KG in International Archives of Otorhinolaryngology
- Vol. 26 (01) , e132-e136
Progressive Increase Trend in HPV-Related Oropharyngeal Squamous Cell Carcinoma in Brazil
Introduction The prevalence of oropharyngeal squamous cell carcinoma (OSCC) related to Human Papillomavirus (HPV) is rising in the whole world.Objective To access the prevalence and temporal trend of HPV infection in oropharyngeal cancer by analyzing the expression of the p16 protein.Methods We conducted a transversal study in a Brazilian reference oncology center. The sample consisted of 254 patients with OSCC. The analyzed period was from 2013 to 2017. All patients underwent p16 immunohistochemistry analysis.Results The overall prevalence of HPV-related OSCC was of 31.9%. During the analyzed period, we observed a trend of increasing rates of OSCC that marked positive for p16 immunohistochemistry. The annual prevalence of p16-positive cases was of 20.6% in 2013, 23.9% in 2014, 33.3% in 2015, 38.3% in 2016, and 34.2% in 2017. Most of the patients were stage III and IV (84%). Female patients (odds ratio [OR] = 2.43; 95% confidence interval [CI]: 1.003–5.888; p = 0.049) and younger patients (OR = 2.919; 95%CI: 1.682–5.067; p < 0.005) were associated with a higher risk of HPV-related OSCC. Tobacco consumption had a proportional lower risk of HPV-related OSCC (OR = 0.152; 95%CI: 0063–0.366; p < 0.005).Conclusion We observed an increasing prevalence of HPV-related OSCC in a specialized cancer hospital in Brazil.
- 13 August 2021
- Published by Georg Thieme Verlag KG in International Archives of Otorhinolaryngology
- Vol. 26 (01) , e132-e136
Open AccessProgressive Increase Trend in HPV-Related Oropharyngeal Squamous Cell Carcinoma in Brazil
Introduction The prevalence of oropharyngeal squamous cell carcinoma (OSCC) related to Human Papillomavirus (HPV) is rising in the whole world.Objective To access the prevalence and temporal trend of HPV infection in oropharyngeal cancer by analyzing the expression of the p16 protein.Methods We conducted a transversal study in a Brazilian reference oncology center. The sample consisted of 254 patients with OSCC. The analyzed period was from 2013 to 2017. All patients underwent p16 immunohistochemistry analysis.Results The overall prevalence of HPV-related OSCC was of 31.9%. During the analyzed period, we observed a trend of increasing rates of OSCC that marked positive for p16 immunohistochemistry. The annual prevalence of p16-positive cases was of 20.6% in 2013, 23.9% in 2014, 33.3% in 2015, 38.3% in 2016, and 34.2% in 2017. Most of the patients were stage III and IV (84%). Female patients (odds ratio [OR] = 2.43; 95% confidence interval [CI]: 1.003–5.888; p = 0.049) and younger patients (OR = 2.919; 95%CI: 1.682–5.067; p < 0.005) were associated with a higher risk of HPV-related OSCC. Tobacco consumption had a proportional lower risk of HPV-related OSCC (OR = 0.152; 95%CI: 0063–0.366; p < 0.005).Conclusion We observed an increasing prevalence of HPV-related OSCC in a specialized cancer hospital in Brazil.
- Open Access
- 21 June 2021
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 30 (9) , 1697-1707
HPV-Induced Oropharyngeal Squamous Cell Carcinomas in Brazil: Prevalence, Trend, Clinical, and Epidemiologic Characterization
Background: Tobacco or human papillomavirus (HPV)-related oropharyngeal squamous cell carcinomas (OPSCC) represent different clinical and epidemiologic entities. This study investigated the prevalence of HPV-positive and HPV-negative OPSCC in a reference cancer hospital in Brazil and its association with clinical and demographic data, as well as its impact on overall survival.Methods: HPV infection was determined by p16-IHC in pre-treatment formalin-fixed paraffin-embedded samples from all patients with OPSCC diagnosed at Barretos Cancer Hospital between 2008 and 2018. The prevalence of HPV-positive cases and its temporal trend was assessed, and the association of clinical and demographic data with HPV infection and the impact on patient overall survival was evaluated.Results: A total of 797 patients with OPSCC were included in the study. The prevalence of HPV-associated tumors in the period was 20.6% [95% confidence interval, 17.5–24.0] with a significant trend for increase of HPV-positive cases over the years (annual percentage change = 12.87). In a multivariate analysis, the variables gender, level of education, smoking, tumor sublocation, region of Brazil, and tumor staging had a significant impact in HPV positivity, and a greater overall survival (OS) was observed in HPV-positive patients (5-year OS: 47.9% vs. 22.0%; P = 0.0001).Conclusions: This study represents the largest cohort of Brazilian patients with OPSCC characterized according to HPV status. We report significant differences in demographics and clinical presentation according to HPV status, and an increasing trend in prevalence for HPV-induced tumors.Impact: These findings can potentially contribute to a better stratification and management of patients as well as assist in prevention strategies.
- 21 June 2021
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 30 (9) , 1697-1707
Open AccessHPV-Induced Oropharyngeal Squamous Cell Carcinomas in Brazil: Prevalence, Trend, Clinical, and Epidemiologic Characterization
Background: Tobacco or human papillomavirus (HPV)-related oropharyngeal squamous cell carcinomas (OPSCC) represent different clinical and epidemiologic entities. This study investigated the prevalence of HPV-positive and HPV-negative OPSCC in a reference cancer hospital in Brazil and its association with clinical and demographic data, as well as its impact on overall survival.Methods: HPV infection was determined by p16-IHC in pre-treatment formalin-fixed paraffin-embedded samples from all patients with OPSCC diagnosed at Barretos Cancer Hospital between 2008 and 2018. The prevalence of HPV-positive cases and its temporal trend was assessed, and the association of clinical and demographic data with HPV infection and the impact on patient overall survival was evaluated.Results: A total of 797 patients with OPSCC were included in the study. The prevalence of HPV-associated tumors in the period was 20.6% [95% confidence interval, 17.5–24.0] with a significant trend for increase of HPV-positive cases over the years (annual percentage change = 12.87). In a multivariate analysis, the variables gender, level of education, smoking, tumor sublocation, region of Brazil, and tumor staging had a significant impact in HPV positivity, and a greater overall survival (OS) was observed in HPV-positive patients (5-year OS: 47.9% vs. 22.0%; P = 0.0001).Conclusions: This study represents the largest cohort of Brazilian patients with OPSCC characterized according to HPV status. We report significant differences in demographics and clinical presentation according to HPV status, and an increasing trend in prevalence for HPV-induced tumors.Impact: These findings can potentially contribute to a better stratification and management of patients as well as assist in prevention strategies.
- Open Access
- 23 October 2018
- Published by Springer Nature in BMC Cancer
- Vol. 18 (1) , 1-9
Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
The evolution of radiotherapy over recent decades has reintroduced the hypofractionation for many tumor sites with similar outcomes to those of conventional fractionated radiotherapy. The use of hypofractionation in locally advanced head and neck cancer (LAHNC) has been already used, however, its use has been restricted to only a few countries. The aim of this trial was to evaluate the safety and feasibility of moderate hypofractionated radiotherapy (HYP-RT) with concomitant cisplatin (CDDP). This single-arm trial was designed to evaluate the safety and feasibility of HYP-RT with concomitant CDDP in LAHNC. Stage III and IV patients withnonmetastatic disease were enrolled. Patients were submitted to intensity modulatedradiation therapy, which comprised 55 Gy/20 fractions to the gross tumor and44–48 Gy/20 fractions to the areas of subclinical disease. Concomitant CDDPconsisted of 4 weekly cycles of 35 mg/m2. The primary endpoints were the treatment completion rate and acute toxicity. Twenty patients were enrolled from January 2015 to September 2016, and 12 (60%) were classified as unresectable. All patients completed the total dose of radiotherapy, and 19 patients (95%) received at least 3 of 4 cycles of chemotherapy. The median overall treatment time was 29 days (27–34). Grade 4 toxicity was reported twice (1 fatigue and 1 lymphopenia). The rates of grade 3 dermatitis and mucositis were 30% and 40%, respectively, with spontaneous resolution. Nasogastric tubes were offered to 15 patients (75%) during treatment; 4 patients (20%) needed feeding tubes after 2 months, and only 1 patient needed a feeding tube after 12 months. HYP-RT with concomitant CDDP was considered feasible for LAHNC, and the rate of acute toxicity was comparable to that of standard concomitant chemoradiation. A feeding tube was necessary for most patients during treatment. Further investigation of this strategy is warranted. ClinicalTrials, NCT03194061 . Registered 21 Jun 2017 – Retrospectively registered.
- 23 October 2018
- Published by Springer Nature in BMC Cancer
- Vol. 18 (1) , 1-9
Open AccessFeasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
The evolution of radiotherapy over recent decades has reintroduced the hypofractionation for many tumor sites with similar outcomes to those of conventional fractionated radiotherapy. The use of hypofractionation in locally advanced head and neck cancer (LAHNC) has been already used, however, its use has been restricted to only a few countries. The aim of this trial was to evaluate the safety and feasibility of moderate hypofractionated radiotherapy (HYP-RT) with concomitant cisplatin (CDDP). This single-arm trial was designed to evaluate the safety and feasibility of HYP-RT with concomitant CDDP in LAHNC. Stage III and IV patients withnonmetastatic disease were enrolled. Patients were submitted to intensity modulatedradiation therapy, which comprised 55 Gy/20 fractions to the gross tumor and44–48 Gy/20 fractions to the areas of subclinical disease. Concomitant CDDPconsisted of 4 weekly cycles of 35 mg/m2. The primary endpoints were the treatment completion rate and acute toxicity. Twenty patients were enrolled from January 2015 to September 2016, and 12 (60%) were classified as unresectable. All patients completed the total dose of radiotherapy, and 19 patients (95%) received at least 3 of 4 cycles of chemotherapy. The median overall treatment time was 29 days (27–34). Grade 4 toxicity was reported twice (1 fatigue and 1 lymphopenia). The rates of grade 3 dermatitis and mucositis were 30% and 40%, respectively, with spontaneous resolution. Nasogastric tubes were offered to 15 patients (75%) during treatment; 4 patients (20%) needed feeding tubes after 2 months, and only 1 patient needed a feeding tube after 12 months. HYP-RT with concomitant CDDP was considered feasible for LAHNC, and the rate of acute toxicity was comparable to that of standard concomitant chemoradiation. A feeding tube was necessary for most patients during treatment. Further investigation of this strategy is warranted. ClinicalTrials, NCT03194061 . Registered 21 Jun 2017 – Retrospectively registered.